![[ Nursing Home Photo ]](/media/promo.jpg)
› $150,000,000 verdict in personal injury case
Alfacell, manufacturer of the leading mesothelioma drug ONCONASE, has announced that it has hired financial advisor Oppenheimer & Co. to assist in the company’s “pursuit of available strategic alternatives to enhance shareholder value,” including a possible sale of the company.
Alimta, a medication manufactured by Eli Lilly & Co., which has been used for some time now in the treatment of malignant mesothelioma, has recently been approved as a first-line treatment for lung cancer.
Results of a recently completed study reveal a possible genetic predisposition to developing asbestos related diseases, including mesothelioma and asbestosis. Findings were published August 7 in BMC Genomics, an open access journal publishing original peer-reviewed research articles in all aspects of gene mapping, sequencing and analysis, functional genomics, and proteomics.
![[ Beasley Allen Law Firm Logo ]](/wp-content/themes/system-unity/images/logo.png){kind=logo}